Quantcast
Last updated on April 25, 2014 at 1:22 EDT

Latest Exosome Stories

2013-01-23 08:29:21

SAN DIEGO, Jan. 23, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), announced that President, Rod Kenley will present today at the 15(th) International Conference on Dialysis being hosted by the Renal Research Institute. Mr. Kenley's presentation is entitled: "Extracorporeal Methods to Reduce Inflammation in Acute Sepsis," and is scheduled to begin at 10:25 a.m. Eastern Standard Time. The conference is being held at the Wyndham Rio Mar, Rio Grande, Puerto Rico. Additional details...

2013-01-17 12:26:38

SAN DIEGO, Jan. 17, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, announced today that Laszlo Radvanyi, Ph.D., an Associate Professor in the Department of Melanoma Medical Oncology Research at the University of Texas MD Anderson Cancer Center in Houston, has joined its Scientific Advisory Board. "I am excited to be a part of Aethlon's...

2013-01-15 08:24:26

SAN DIEGO, Jan. 15, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce. (Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b) In 2012, researchers published the discovery that small particles known as exosomes are secreted by tumors to seed the creation and spread of cancer metastases. These same tumor-secreted exosomes have also been implicated in death of immune cells necessary to combat...

2013-01-08 08:30:31

SAN DIEGO, Jan. 8, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), announced that Chief Executive Officer Jim Joyce will give a corporate presentation today at Biotech Showcase 2013. The presentation is scheduled to start at 4:45 p.m. Pacific Standard Time and can be accessed online at http://www.media-server.com/m/p/54bc8kj7. The conference is being held in San Francisco at the Parc 55 Wyndham Union Square Hotel. (Photo:...

2012-12-07 08:24:12

SAN DIEGO, Dec. 7, 2012 /PRNewswire/ --Aethlon Medical, Inc. (OTCBB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce. At Aethlon Medical, our focus is to create revolutionary medical devices that save lives. In the treatment of Hepatitis C (HCV) infected individuals, we have demonstrated that our Hemopurifier® synergistically combines with drug therapy to accelerate the achievement of undetectable viral load. In cancer, I envision our opportunity to...

2012-10-26 07:23:43

NEW YORK, Oct. 26, 2012 /PRNewswire/ -- Exosome Diagnostics today announced it has reached an agreement with Promega Corporation to be the exclusive supplier of its Urine Clinical Sample Concentrator Kit. Promega will manufacture the Clinical Sample Concentrator Kit under current good manufacturing practices (cGMP) in their Madison, Wisconsin manufacturing facility. The kit incorporates Exosome's proprietary method for concentration of urinary exosomes, a standardized approach for providing...

2012-10-25 11:25:18

SAN DIEGO, Oct. 25, 2012 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, disclosed today that U.S. Patent number 8,288,172 was issued to the Company by the U.S. Patent and Trademark Office (USPTO) on October 16(th), 2012. The patent entitled "Extracorporeal Removal of Microvesicular Particles," provides Aethlon Medical the exclusive right to...

2012-10-03 02:27:51

SAN DIEGO, Oct. 3, 2012 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), today released the slide-deck underlying a presentation given yesterday by its Chairman and CEO, Jim Joyce at the EXOSOMES & MICROVESICLES 2012 conference in Orlando, Florida. The presentation was entitled: Extracorporeal clearance of tumor-secreted exosomes as an adjunct to enhance cancer therapy efficacy. (Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b) The presentation focused on the...

2012-09-25 02:29:24

SAN DIEGO, Sept. 25, 2012 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), disclosed today that its Chairman and CEO, Jim Joyce will present at the Exosomes and Microvesicles 2012 conference, which is being hosted by The American Society for Exosomes and Microvesicles. The event will be held at the Wyndham Lake Buena Vista Resort in Orlando, Florida and runs from September 29(th) through October 2(nd). Mr. Joyce's presentation is scheduled for 10:10 a.m. on October 2(nd) and is...

2012-09-11 10:24:58

SAN DIEGO, Sept. 11, 2012 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), disclosed this afternoon that its Chairman and CEO, Jim Joyce, and Chief Science Officer, Dr. Richard Tullis, gave a presentation yesterday at the MD Anderson Cancer Center in Houston, Texas. The presentation was entitled: The extracorporeal removal of tumor-secreted exosomes: An adjunct strategy to reverse immune suppression and inhibit metastases in melanoma. (Photo:...